+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Left Ventricular Assist Device (LVAD) - Global Strategic Business Report

  • PDF Icon

    Report

  • 182 Pages
  • February 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140378

Global Left Ventricular Assist Device (LVAD) Market to Reach $2.3 Billion by 2030

The global market for Left Ventricular Assist Device (LVAD) estimated at US$1.3 Billion in the year 2022, is projected to reach a revised size of US$2.3 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2022-2030. Hospitals, one of the segments analyzed in the report, is projected to record 6.2% CAGR and reach US$1.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Clinics segment is readjusted to a revised 9.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $387.8 Million, While China is Forecast to Grow at 7.2% CAGR

The Left Ventricular Assist Device (LVAD) market in the U.S. is estimated at US$387.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$402.7 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 6.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Select Competitors (Total 13 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • CorWave SA
  • Evaheart, Inc.
  • Jarvik Heart, Inc.
  • ReliantHeart, Inc.
  • Sun Medical Technology Research Corp.
  • Terumo Corporation
  • Transonic Systems, Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Left Ventricular Assist Device (LVAD)

What is the estimated value of the Global Market for Left Ventricular Assist Device (LVAD)?

The Global Market for Left Ventricular Assist Device (LVAD) was estimated to be valued at $1.3 Billion in 2022.

What is the growth rate of the Global Market for Left Ventricular Assist Device (LVAD)?

The growth rate of the Global Market for Left Ventricular Assist Device (LVAD) is 7.4%, with an estimated value of $2.3 Billion by 2030.

What is the forecasted size of the Global Market for Left Ventricular Assist Device (LVAD)?

The Global Market for Left Ventricular Assist Device (LVAD) is estimated to be worth $2.3 Billion by 2030.

Who are the key companies in the Global Market for Left Ventricular Assist Device (LVAD)?

Key companies in the Global Market for Left Ventricular Assist Device (LVAD) include Abbott Laboratories, Abiomed, Inc., Berlin Heart GmbH, CorWave SA, Evaheart, Inc., Jarvik Heart, Inc., ReliantHeart, Inc., Sun Medical Technology Research Corp., Terumo Corporation and Transonic Systems, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Left Ventricular Assist Device (LVAD) - Global Key Competitors Percentage Market Share in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Left Ventricular Assist Device (LVAD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Left Ventricular Assist Device (LVAD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 13: World Left Ventricular Assist Device (LVAD) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 14: USA Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 15: USA Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 16: USA 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
CANADA
  • Table 17: Canada Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 18: Canada Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 19: Canada 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
JAPAN
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 20: Japan Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 21: Japan Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 22: Japan 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
CHINA
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 23: China Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: China Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 25: China 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
EUROPE
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 26: Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Left Ventricular Assist Device (LVAD) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 28: Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 29: Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 31: Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
FRANCE
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 32: France Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: France Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 34: France 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
GERMANY
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 35: Germany Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Germany Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 37: Germany 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
ITALY
  • Table 38: Italy Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: Italy Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 40: Italy 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 41: UK Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: UK Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 43: UK 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 44: Rest of Europe Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: Rest of Europe Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 46: Rest of Europe 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • Left Ventricular Assist Device (LVAD) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 47: Asia-Pacific Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 48: Asia-Pacific Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 49: Asia-Pacific 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
REST OF WORLD
  • Table 50: Rest of World Recent Past, Current & Future Analysis for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: Rest of World Historic Review for Left Ventricular Assist Device (LVAD) by End-Use - Hospitals, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 52: Rest of World 16-Year Perspective for Left Ventricular Assist Device (LVAD) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics and Other End-Uses for the Years 2014, 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Abiomed, Inc.
  • Berlin Heart GmbH
  • CorWave SA
  • Evaheart, Inc.
  • Jarvik Heart, Inc.
  • ReliantHeart, Inc.
  • Sun Medical Technology Research Corp.
  • Terumo Corporation
  • Transonic Systems, Inc.